Kalocyte
Baltimore, US · 2 known investors
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply. The pre-clinical stage biotech company is supported by federal grants and investor funding.
BiotechDeep TechHealthtechMedical Devices
Founders & leadership
<
<UNKNOWN>
AD
Allan DoctorCo-Founder & CSO
DP
Dipanjan PanCo-Founder, Chief Technical Officer
PS
Philip SpinellaCo-Founder, Chief Medical Officer
PS
Phil Spinella